DigiPharma 2027 | Pharma Marketing & Sales Conference

For Pharma Leaders Shaping the Future of Digital Engagement

DigiPharma, formerly Future Pharma, is where pharma’s marketing, sales, and commercial leaders tackle the challenges shaping patient and HCP engagement. DigiPharma is for leaders building a more orchestrated, evidence-driven, and human future for pharma commercialization.

Download Agenda

2026 Speakers

See All Speakers

DigiPharma is built for practitioners, by practitioners. Participate in candid discussions from innovators sharing real strategies that drive commercial success.

Connie Lieu

Head of IT, US Hematology & Oncology, Commercial IT

Bristol Myers Squibb

Jason Moyer

Head of Assets and Optimization, US Rare Disease

UCB

Georgette Charles

Director of Market Insights & Intelligence

UCB

Daniel Fernandez

Director, Commercial Strategy

Genentech

Dr. Nadia Khatri

Director, Worldwide Media & Strategic Planning, HCP

Bristol Myers Squibb

Chris Jones

Director of Access, Care Experience, Care Transformation, and External Medical

Kaiser Permanente

Farrell Simon

Chief Commercial Officer

Trevi Therapeutics

Stephanie Loiseau

Senior Director Marketing

Sun Pharma

Transform Your Career in Two Days

↗

The Most Senior Pharma Speaker Faculty

Hear candid insights from top pharma executives on where the industry stands and where it’s headed. DigiPharma is built for peer-to-peer learning and fosters relationships that last well beyond the conference.

↗

Focused on Execution, Not Experimentation

DigiPharma is where you'll explore omnichannel, commercial, and patient-centric strategies through interactive sessions and proven case studies. Walk away with real frameworks to help you elevate the customer and patient experience.

↗

The Biggest Payback on Your Time Out of Office

The commercial model is no longer about adding more tools; it’s about integrating the ones that matter. Every moment at DigiPharma is designed for real-world impact, ensuring that you leave with actionable tools to drive success for the business and the patient.